WO2008117338A1 - Système de mesure de consommation d'oxygène et dispositif de diagnostic - Google Patents

Système de mesure de consommation d'oxygène et dispositif de diagnostic Download PDF

Info

Publication number
WO2008117338A1
WO2008117338A1 PCT/JP2007/000308 JP2007000308W WO2008117338A1 WO 2008117338 A1 WO2008117338 A1 WO 2008117338A1 JP 2007000308 W JP2007000308 W JP 2007000308W WO 2008117338 A1 WO2008117338 A1 WO 2008117338A1
Authority
WO
WIPO (PCT)
Prior art keywords
oxygen consumption
variation
retina
detecting means
light source
Prior art date
Application number
PCT/JP2007/000308
Other languages
English (en)
Inventor
Rushen Bhikhubhai Patel
Original Assignee
Aqumen Biopharmaceuticals K.K.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aqumen Biopharmaceuticals K.K. filed Critical Aqumen Biopharmaceuticals K.K.
Publication of WO2008117338A1 publication Critical patent/WO2008117338A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/12—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes
    • A61B3/1225—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes using coherent radiation
    • A61B3/1233—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes using coherent radiation for measuring blood flow, e.g. at the retina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • A61B5/14555—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases specially adapted for the eye fundus

Definitions

  • the present invention relates to an oxygen consumption measurement system, diagnostic system, and the like.
  • a pulse oximeter that is an apparatus for measuring the blood oxygen saturation is disclosed.
  • a pulse oximeter is a medical instrument for noninvasively monitoring pulse rate and percutaneous arterial oxygen saturation by attaching a probe to a fingertip or an ear.
  • a pulse oximeter takes advantage of the difference in absorbance between oxygenated hemoglobin and reduced hemoglobin.
  • the pulse oximeter since most of pulsatings in peripheral tissues are attributable to arterial blood, and quantity of transmitted light is also pulsative in accordance with quantity of arterial blood, the pulse oximeter adopts a method of taking out only the pulsative portion thereof, and measures the absorbance for a plurality of lights having different wavelengths, thereby measuring arterial blood oxygen saturation from a ratio of measurements of absorbance.
  • Patent Citation 1 Japanese patent application laid-open No. 7-171139
  • Patent Citation 2 Japanese patent application laid-open No. 7-155312
  • the present invention is based on a knowledge that a variation in oxygen consumption in the retina can be obtained basically by measuring blood flow of the retina and by obtaining oxygen saturation within the retina.
  • the first aspect of the present invention is related to an oxygen consumption measurement system provided with: a laser light source (1); a first optical detecting means (3) detecting a light outputted from the laser light source (1) having entered an eye (2) of a subject and having been reflected thereby; a multiple wavelength light source (4); a second optical detecting means (5) detecting a light emitted from the multiple wavelength light source (4) having entered the eye (2) of the subject and having been reflected thereby; and a controller (6) connected to the first optical detecting means (3) and the second optical detecting means (5), which obtains a blood flow in a retina using a detected signal detected by the first optical detecting means (3), obtains an oxygen saturation using a detected signal detected by the second optical detecting means (5), and obtains a variation in oxygen consumption in the retina using the blood flow in the retina and the oxygen saturation
  • a preferred embodiment of the first aspect of the present invention is related to the above-mentioned oxygen consumption measurement system, further provided with a scanning portion for scanning the laser light source (1).
  • a preferred embodiment of the first aspect of the present invention is related to any one of the above-mentioned oxygen consumption measurement systems, further provided with a positioning means for displacing an irradiating position of the laser light source (1) or the multiple wavelength light source (4) in accordance with a displacement of the eye (2) of the subject.
  • a preferred embodiment of the first aspect of the present invention is related to any one of the above-mentioned oxygen consumption measurement systems, wherein: the multiple wavelength light source (4) comprises a single light source (7), and a filtering portion (8) through which a light from the optical source (7) is transmitted; and the filtering portion (8) comprises a plurality of optical filters having mutually different transmission characteristics.
  • a preferred embodiment of the first aspect of the present invention is related to any one of the above-mentioned oxygen consumption measurement systems, wherein the controller (6) outputs an indication signal for indicating at least one of the blood flow in the retina, a distribution of the oxygen saturation, and a distribution of the variation in oxygen consumption.
  • a preferred embodiment of the first aspect of the present invention is related to any one of the above-mentioned oxygen consumption measurement system, wherein a single CCD camera is the first optical detecting means (3) and the second optical detecting means (5).
  • a preferred embodiment of the first aspect of the present invention is related to any one of the above-mentioned oxygen consumption measurement systems, wherein a variation in arterial oxygen consumption is obtained.
  • a preferred embodiment of the first aspect of the present invention is related to any one of the above-mentioned oxygen consumption measurement systems, wherein a variation in venous oxygen consumption is obtained.
  • a preferred embodiment of the first aspect of the present invention is related to any one of the above-mentioned oxygen consumption measurement systems, which is used for monitoring a variation in blood oxygen consumption.
  • the second aspect of the present invention is related to a diagnostic system provided with any one of the above-mentioned oxygen consumption measurement systems, which obtains the variation in oxygen consumption in the retina with the oxygen consumption measurement system, and evaluates whether the subject is affected or is at a risk of being affected by an ophthalmic disease by the variation in oxygen consumption obtained.
  • a preferred embodiment of the second aspect of the present invention is related to a diagnostic system provided with any one of the above-mentioned oxygen consumption measurement systems, which obtains the variation in oxygen consumption in the retina as well as a variation in blood vessel diameter in the retina with the oxygen consumption measurement system, and indicates the variation in oxygen consumption and the variation in blood vessel diameter obtained
  • a preferred embodiment of the second aspect of the present invention is related to a diagnostic system provided with any one of the above-mentioned oxygen consumption measurement systems, which obtains the variation in oxygen consumption in the retina as well as a variation in blood vessel diameter in the retina with the oxygen consumption measurement system, and measures a blood pressure with the sphygmomanometer, in order to control a cardiovascular system from the variation in oxygen consumption, the variation in blood vessel diameter, and the blood pressure obtained.
  • the third aspect of the present invention is related to a method of diagnosing an ophthalmic disease by: using an oxygen consumption measurement system comprising: a laser light source (1); a first optical detecting means (3) detecting a light outputted from the laser light source (1) having entered an eye (2) of a subject and having been reflected thereby; a multiple wavelength light source (4); a second optical detecting means (5) detecting a light emitted from the multiple wavelength light source (4) after having entered the eye (2) of the subject and having been reflected thereby; and a controller (6) connected to the first optical detecting means (3) and the second optical detecting means (5), which obtains a blood flow in a retina using a detected signal detected by the first optical detecting means (3), obtains an oxygen saturation using a detected signal detected by the second optical detecting means (5), and obtains a variation in oxygen consumption in the retina using the blood flow in the retina and the oxygen saturation; obtaining a distribution of the variation in oxygen consumption in the retina with the oxygen consumption measurement system; and evaluating
  • a preferred embodiment of the third aspect of the present invention is related to a method of diagnosing a situation of a cardiovascular system by: using an oxygen consumption measurement system comprising: a laser light source (1); a first optical detecting means (3) detecting a light outputted from the laser light source (1) having entered an eye (2) of a subject and having been reflected thereby; a multiple wavelength light source (4); a second optical detecting means (5) detecting a light emitted from the multiple wavelength light source (4) having entered the eye (2) of the subject and having been reflected thereby; and a controller (6) connected to the first optical detecting means (3) and the second optical detecting means (5), which obtains a blood flow in a retina using a detected signal detected by the first optical detecting means (3), obtains an oxygen saturation using a detected signal detected by the second optical detecting means (5), and obtains a variation in oxygen consumption in the retina using the blood flow in the retina and the oxygen saturation; obtaining a distribution of the variation in oxygen consumption in the retina as well as
  • a preferred embodiment of the third aspect of the present invention is related to the above-mentioned method of diagnosing, further measuring a blood pressure with a sphygmomanometer, wherein the situation of the cardiovascular system is diagnosed by using the variation in oxygen consumption in the retina, the variation in blood vessel diameter, and the blood pressure.
  • an oxygen consumption measurement system capable of obtaining a variation in oxygen consumption in each position of a retina by obtaining blood flow and oxygen saturation in the retina.
  • an oxygen consumption measurement system capable of easily monitoring a variation in blood oxygen saturation of a central blood vessel during medical treatment.
  • FIG.l is a conceptual diagram showing a basic arrangement of an oxygen consumption measurement system of the present invention.
  • FIG.2 is a schematic diagram showing a laser speckle apparatus.
  • FIG.3 is a schematic diagram of a portion in an apparatus related to oximetry.
  • FIG.4 is a conceptual diagram showing how a blood flow measurement and an oximetry imaging are simultaneously performed, whereby oxygen consumption is obtained.
  • Fig. 1 is a conceptual diagram showing a basic arrangement of an oxygen consumption measurement system of the present invention.
  • the oxygen consumption measurement system of the present invention is basically provided with a laser light source (1), a first optical detecting means (3) detecting a light outputted from the laser light source (1) having entered an eye (2) of a subject and having been reflected thereby, a multiple wavelength light source (4), a second optical detecting means (5) detecting a light emitted from the multiple wavelength light source (4) having entered the eye (2) of the subject and having been reflected thereby; and a controller (6) connected to the first optical detecting means (3) and the second optical detecting means (5), which obtains a blood flow in a retina using a detected signal detected by the first optical detecting means (3), obtains an oxygen saturation using a detected signal detected by the second optical detecting means (5), and obtains a variation in oxygen consumption in the retina using the blood flow in the retina and the oxygen saturation
  • an apparatus, a method, and a principle for measuring blood flow using a laser light source are publicly known as described, for example, in Japanese patent application laid-open No. 1-249722.
  • Use of a LSFG or a Laser- Doppler technology can be mentioned for measuring blood flow with a laser light source.
  • a preferred aspect of the present invention preliminarily obtains concavity and convexity of the surface of the retina by using the laser light source, and adjusts the focal position of the laser light source along the concavity and convexity of the surface.
  • information related to the surface of the retina may be received by a controlling apparatus, whereby positions of lens system such as a condenser are adjusted as appropriate.
  • the light reaches the retina through the cornea and the vitreous body, it is desirable to take into account influences of the cornea and the vitreous body.
  • the eye may be displaced or traced during the measurement. Accordingly, the variation in blood oxygen consumption may be obtained by widely measuring the retina area to obtain an average.
  • a positioning means for displacing an irradiating position of the laser light source (1) or the multiple wavelength light source (4) in accordance with the displacement of the eye (2) of the subject is a preferred aspect of the present invention.
  • a servomechanism may be provided for displacing laser light source, a multiple wavelength light source, or a light source for tracing the eyeball for observing a specific position (e.g. macula) in the eyeball, monitoring a variation of the specific position, and for displacing the laser light source or the multiple wavelength light source.
  • a specific position e.g. macula
  • the laser light source and the like may be scanned, or an image of a CCD or the like may be scanned, whereby an area where a variation in color or the like is within a predetermined range or where a width of the area thus found is within a predetermined range is observed.
  • scanning laser ophthalmoscope As disclosed in the document, using scanning laser ophthalmoscope make us be able to determine the location of images of visual target. Tracking the movement of the eye could be attained by using software, e.g., Block matching. Using such software, the calculation can be done in real time so that the image of blood flow and/ or oxygen consumption displayed on the computer screen is stable.
  • a laser light source what is publicly known to be used for the LSFG may be used as appropriate.
  • a specific laser wavelength an infrared wavelength can be mentioned.
  • a wavelength from 750nm to 850nm inclusive can be mentioned.
  • an optical system one having a semiconductor laser such as a diode laser with a temperature controller, a projector lens for focusing the light from the semiconductor laser, and an aperture thought which the light outputted from the projector lens is transmitted can be mentioned.
  • a laser light one that passes through the projector lens and the aperture, and focuses on the surface of the cornea is preferable. By thus focusing, the laser light after having passed through tissues (e.g.
  • a preferable laser light source has a scanning portion for scanning the laser light source (1). In the presence of a scanning portion, the laser light source can be scanned within the eyeball to observe blood flow ate the predetermined region.
  • the first optical detecting means is not specifically limited as long as being capable of detecting light and a publicly known optical detecting means may be used as appropriate. Specifically, a publicly known optical detector such as a publicly known photo diode and CCD can be mentioned.
  • the laser When the laser reaches the surface of the retina, the laser scatters and reflects various structures in the tissue. Some light reaches the choroids by reaching lower portions of the retina without being reflected. This backscattered light forms a speckle image on the graphics in the observation optical system.
  • a light intensity at a given point can be determined by the sum of the intensities of the backscattered light. If a resultant intensity is zero, a dark speckle image can be obtained at the point, while a maximum intensity is observed if all images arrive. Thus, a speckle image can be obtained.
  • the speckle image is fluctuated by particles within the tissue. Since a backscatter by static particles forms a speckle pattern, by observing the speckle image, two components, a static component and a dynamic component can be obtained.
  • a technology for obtaining the blood flow using a reflected light is publicly known as the LSFG, so that the controller of the present invention may be mounted on a computer or the like having a program for obtaining the blood flow from the reflected light based on the LSFG technology stored in a main memory or the like.
  • the controller of the present invention may be mounted on a computer or the like having a program for obtaining the blood flow from the reflected light based on the LSFG technology stored in a main memory or the like.
  • the laser light source or the like may be scanned, or an image of a CCD or the like may be scanned, whereby an area where a variation in color or the like is within a predetermined range or where a width of the area found is within a predetermined range is measured.
  • a variation in blood vessel diameter at a certain point can be observed by using in combination with the tracing means described above as appropriate.
  • a marking method of the blood vessel location for example, a location where the blood vessel branches is confirmed, the pattern of the branching is stored, and a branching location is recognized by checking whether or not it matches the stored branching pattern, so that the blood vessel diameter at the branching point may be measured, or the blood vessel diameter at a location shifted from the branching point by a predetermined location may be measured.
  • a multiple wavelength light source is not specifically limited as long as being capable of generating plural kinds of light including at least a light with the wavelength at the vicinity of 600nm, and a publicly known multiple wavelength light source can be adopted.
  • a plurality of single optical lasers of different wavelengths may be used as well.
  • a multiple wavelength light source may be provided with a single light source (7), and a filtering portion (8) through which a light from the optical source (7) is transmitted, and the filtering portion (8) may be provided with a plurality of optical filters having mutually different transmission characteristics. Specifically, for example, one provided with six filters at locations that are 60 degrees shifted from each other on a circular filter board, which is sequentially switched over to one with preferable transmission characteristics.
  • the controller of the present invention may be mounted on a computer or the like having a program for obtaining the oxygen saturation from the information of the reflected light based on the oximetry technology stored in a main program or the like.
  • the controller is provided with a an input device, output device, storage device such as a memory, arithmetic device such as the CPU, and a controller, the devices are mutually connected with busses or the like, so that information can be transmitted and received.
  • the input device is connected to a detecting system such as various types of photodetectors so that to be able to input information to the controller.
  • a preferred embodiment of the present invention presets the amounts of absorbance by the cornea and the vitreous body, whereby the absorbance is obtained by adjusting the portion of the preset absorbance. Specifically, this can be implemented, for example, as follows: Firstly, the absorbance of the light having passed through the retina is obtained.
  • the constants corresponding to absorbance of the cornea and the vitreous body are retrieved upon calculating the absorbance of the light having passed through the retina.
  • a difference is obtained by subtracting the retrieved constants corresponding to absorbance of the cornea and the vitreous body from the absorbance obtained by using a difference circuit or by using a difference operation program.
  • the absorbance in the retina may be obtained. It is to be noted that a thickness of the vitreous body may be measured, whereby the absorbance of the vitreous body is given by a value that is the thickness multiplied by the absorbance (constant) for the unit thickness.
  • the absorbance can be measured more accurately. For example, it is possible to consider only the absorbance of the vitreous body. Specifically, an absorbance constant of the vitreous body that is general or measured per test body is stored. Also, the thickness of the vitreous body is measured by a publicly known method, and the thickness of the vitreous body per test body is stored. The stored absorbance constant of the vitreous body and the thickness of the vitreous body are retrieved, and a multiplication operation by using a multiplication circuit or a multiplication operation program is performed, whereby the absorbance in the vitreous body is obtained to be stored in the memory. Then, the absorbance of light having passed through the retina is obtained. The absorbance of the vitreous body stored in the memory is retrieved.
  • a difference is obtained by subtracting the retrieved absorbance of the vitreous body from the absorbance obtained by using a difference circuit or by using a difference operation program.
  • the absorbance in the retina may be obtained.
  • the controller of the present invention can obtain the variation in oxygen consumption in the retina by using the blood flow in the retina and the oxygen saturation.
  • the variation in oxygen consumption in the retina can be indicated by taking a certain constant value as a reference, and the amount of multiples of the reference value may be regarded as "the variation in oxygen consumption in the retina".
  • the reference value is prestored.
  • the light may be irradiated on a portion other than the blood vessel in the retina.
  • the oxygen consumption in the portion other than the blood vessel is obtained.
  • the obtained oxygen consumption is stored in the memory as a reference value.
  • the oxygen consumption at each point in the retina is obtained.
  • the reference value stored in the memory is retrieved, and the obtained oxygen consumption at each portion is divided by the retrieved reference value.
  • the a divider circuit or a division operation program may be used. "The variation in oxygen consumption in the retina" can be thus obtained. Also, taking the oxygen consumption in the retina measured at a certain point of time as a reference, an amount indicating the level of variation from the reverence value can be mentioned. Alternatively, by measuring the oxygen consumption for a plurality of times, the maximum value and the minimum value thereof may be obtained, and the value obtained by dividing the maximum value by the minimum value may be regarded as "the variation in oxygen consumption in the retina".
  • the smallest area for obtaining "the variation in oxygen consumption in the retina” varies according to the accuracy of the optical system and the optical detecting means.
  • the controller (6) outputs an indication signal indicating at least one of the blood flow in the retina, the distribution of the oxygen saturation, and the variation in oxygen consumption.
  • the output devices such as a monitor can create a two-dimensional picture of the variation in oxygen consumption and the like, so that by continuously monitoring the picture, the variation in the oxygen consumption and the like can be monitored.
  • a variation in living body during treatment of diseases such as cardiac disease, pulmonary disease, or ophthalmic disease, or the like can be monitored.
  • a variation in oxygen consumption can be obtained by using a blood flow volume, a total amount of hemoglobin, and an amount of deoxyhemoglobin.
  • the blood flow volume can be obtained by using the LSFG and the like, while the total amount of hemoglobin and the amount of deoxyhemoglobin can be obtained by using a technology developed by the oximetry for obtaining the oxygen saturation.
  • the oxygen consumption (metabolic rate of oxygen: MRO 2 ) can be obtained by using a blood flow volume and an fluctuation of oxygen extraction.
  • MRO 2 can be obtained by BF x OEF.
  • OEF can be obtained as (S A -S V )/S A where arterial oxygen saturation is expressed as S A , and venous oxygen saturation is expressed as S v .
  • S A and S v are stored in the memory to be retrieved as appropriate.
  • S A -S V )/S A is obtained by using the retrieved values of S A and Sv with a circuit for four arithmetic operations.
  • the value of (S A -S V )/S A may be retrieved by using the retrieved values of S A and S v .
  • (S A -S V )/S A may be obtained by having an operating portion operate the value of (S A -S V )/S A by using the retrieved values of S A and S v .
  • the value of the BF obtained is stored in the memory.
  • the value of MRO 2 may be obtained by using the value of BF and the value of (S A -S V )/S A with a multiplying circuit or by having the operating portion perform the multiplication calculation.
  • a preferred embodiment of the present invention has a single CCD camera serves as both of the first optical detecting means (3) and the second optical detecting means (5).
  • a single light receiving element By using a single light receiving element, downsizing can be achieved.
  • the oxygen saturation is obtained after measuring the blood flow in the system of the present invention, not only the variation in arterial oxygen consumption but also the variation in venous oxygen consumption are obtained. Namely, since the arterial blood and the venous blood have different colors and the like, in the preferred aspect of the present invention a CCD camera and the like recognizes the difference to obtain the oxygen consumption in the blood vessel where the desired blood flows.
  • the preferred embodiment of the present invention obtains variations in oxygen consumption in portions of the retina, classifies the variations into multiple stages, and shows the variations by the classified ranges in different colors.
  • the second aspect of the present invention is provided with the above- mentioned oxygen consumption measurement system, which obtains a variation in oxygen consumption in the retina with the oxygen consumption measurement system, and evaluates whether the subject is affected or is at a risk of being affected by an ophthalmic disease (specifically, diseases involving cytopathy and the like in new blood vessel or retinal blood vessel such as glaucoma, age related macular degeneration, diabetic retinopathy, retinal artery obstruction, retinal venous obstruction, central serous chorioretinopathy, central exudative chorioretinitis, retinal detachment, pigmentary degeneration of retina, neovascular maculopathy, macular hole, or proliferative vitreoretinopathy) by the variation in oxygen consumption obtained.
  • an ophthalmic disease specifically, diseases involving cytopathy and the like in new blood vessel or retinal blood vessel such as glaucoma, age related macular degeneration, diabetic retinopathy, retinal artery obstruction, retinal venous obstruction,
  • the evaluated risk is indicated on a monitor or the like.
  • the variation in oxygen consumption in the retina when the variation in oxygen consumption is small in a certain portion, it is presumed that the function of the portion is declined or the portion is disordered, so that diagnosis of whether or not the subject is affected by age related macular degeneration or diabetic retinopathy is made possible.
  • a preferred aspect of the present invention is a method of diagnosing glaucoma, age related macular degeneration, or diabetic retinopathy by using an oxygen consumption measurement system provided with: a laser light source (1); a first optical detecting means (3) detecting a light outputted from the laser light source (1) having entered an eye (2) of a subject and having been reflected thereby; a multiple wavelength light source (4); a second optical detecting means (5) detecting a light emitted from the multiple wavelength light source (4) after having entered the eye (2) of the subject and having been reflected thereby; and a controller (6) connected to the first optical detecting means (3) and the second optical detecting means (5), which obtains a blood flow in a retina using a detected signal detected by the first optical detecting means (3), obtains an oxygen saturation using a detected signal detected by the second optical detecting means (5), and obtains a relative value of oxygen consumption in the retina using the blood flow in the retina and the oxygen saturation; obtaining a distribution of variation in oxygen consumption in
  • a preferred embodiment of the present invention is a diagnostic system which is provided with an oxygen consumption measurement system, obtains the variation in oxygen consumption in the retina as well as a variation in blood vessel diameter in the retina with oxygen consumption measurement system, and indicates the variation in oxygen consumption and the variation in blood vessel diameter obtained.
  • an angiospasm may cause heart failure and myocardial infarction.
  • an angiospasm in brain may cause subarachnoid bleeding and subsequent occurrence or brain ischemia.
  • Such an angiospasm can be caused by some sort of factor upon surgical operation. Therefore, it is desirable to perform monitoring of the cardiovascular system especially during an operation.
  • the blood vessel diameter in the retina is recognized. Namely, in the preferred embodiment of the present invention, not only the variation in oxygen consumption is monitored but also the blood vessel diameter in the retina is monitored, so that a sudden change in the cardiovascular system can be easily recognized and can be dealt with promptly.
  • the present invention also provides a method of diagnosing a situation of a cardiovascular system by using an oxygen consumption measurement system provided with: a laser light source (1); a first optical detecting means (3) detecting a light outputted from the laser light source (1) having entered an eye (2) of a subject and having been reflected thereby; a multiple wavelength light source (4); a second optical detecting means (5) detecting a light emitted from the multiple wavelength light source (4) having entered the eye (2) of the subject and having been reflected thereby; and a controller (6) connected to the first optical detecting means (3) and the second optical detecting means (5), which obtains a blood flow in a retina using a detected signal detected by the first optical detecting means (3), obtains an oxygen saturation using a detected signal detected by the second optical detecting means (5), and obtains a variation in oxygen consumption in the retina using the blood flow in the retina and the oxygen saturation; obtaining a distribution in the variation in oxygen consumption in the retina as well as a variation in blood vessel diameter in the retina with the
  • a preferred embodiment of the present invention is a diagnostic system provided with the above-mentioned oxygen consumption measurement system and a sphygmo- manometer, which obtains the variation in oxygen consumption in the retina as well as a variation in blood vessel diameter in the retina with the oxygen consumption measurement system, and measures a blood pressure with the sphygmomanometer, in order to control a cardiovascular system from the variation in oxygen consumption, the variation in blood vessel diameter, and the blood pressure obtained. Since the blood pressure is important information on the cardiovascular system, an appropriate diagnosis can be performed by additionally obtaining information on the blood pressure.
  • the present invention also provides a method of diagnosing by measuring a blood pressure with a sphygmomanometer, wherein the situation of the cardiovascular system is diagnosed by using the variation in oxygen consumption, the variation in blood vessel diameter, and the blood pressure.
  • Mode for the Invention 1
  • Fig. 2 is a schematic diagram of a laser speckle apparatus.
  • the optical system includes, for example, a semiconductor laser such as a diode laser including a temperature controller, a projector lens for focusing light from the semiconductor laser, and an aperture through which the light outputted from the projector lens is transmitted. After passing through the projector lens and the aperture, the laser light is focused on the corneal surface. By such a focusing, the laser is irradiated on a wide area of the retina after passing through tissues within the eyeball.
  • the laser When the laser reaches the surface of the retina, the laser scatters and reflects various structures of the tissue. Some light reaches the choroids by reaching lower portions of the retina without being reflected. This backscattered light forms a speckle image on the graphics in the observation optical system.
  • a light intensity at a given point can be determined by the sum of the intensities of the backscattered light. If a resultant intensity is zero, a dark speckle image can be obtained at the point, while a maximum intensity is observed if all images arrive. Thus, a speckle image can be obtained.
  • the speckle image is fluctuated by particles within the tissue. Since a backscatter by static particles forms a speckle pattern, by observing the speckle image, two components, a static component and a dynamic component can be obtained.
  • FIG. 3 is a schematic diagram showing a potion of an apparatus related to oximetry.
  • a wheel-like filtering apparatus having 6 filters for changing the wavelength of light that reaches the retina and other tissues through liquid light guide.
  • the wheel-like filter is rotated by a stepping motor which is synchronized with a light receiving camera for observation using photodiodes.
  • a light receiving camera for observation using photodiodes.
  • reflection images for 6 different wavelengths can be obtained.
  • Each of the 6 images is converted into oxyhemoglobin, deoxyhemoglobin and total hemoglobin based on a formula conforming to a modified Beer-Lambert law.
  • ⁇ A( ⁇ , t) ( ⁇ Hb o ( ⁇ )AC mo ( ⁇ + ⁇ H b ⁇ (A) ⁇ C HbR ( ⁇ )D( ⁇ )
  • Delta A(lambda,t) indicates an attenuation in of the wavelengths obtained by Log(R(/R(t)), R 0 and R(t) indicate reflectance intensities at baseline and at a time t, respectively.
  • Delta C Hb o and Delta C Hb R indicate variations in oxygen consumption for oxyhemoglobin and deoxyhemoglobin, respectively.
  • Ipusiron Hbo and Ipusiron H b indicate respective molar extinction coefficients. The above formula is obtained for each of the cells of the CCD camera.
  • Da(lambda) that is a coefficient of difference in optical path length is an important factor when obtaining the variation in oxygen consumption. Da is accounts for the fact that optical characteristics of the tissues depend on wavelength. As a matter of fact, the detected light travels through slightly different distances to be detected. In order to accurately obtain the hemoglobin consumption, this dependency on wavelength must be considered, whereby such a dependency of wavelength can be achieved by considering a Monte Carlo model.
  • Fig. 4 is a conceptual diagram showing how a blood flow measurement and an oximetry imaging are simultaneously performed, whereby oxygen consumption is obtained.
  • two cameras were used for speckle measurements and multi- spectrum measurements.
  • the wavelength of the speckle laser has a longer wavelength than the wavelength of the multiple wavelength light source, so that lights originated by the respective light sources can be effectively separated by using a dichroic beam splitter and band pass filters, and also can be guided to the appropriate mirrors.
  • the oxygen consumption measurement system and diagnostic system of the present invention can be used in the fields of medical instruments, and the like

Abstract

L'invention concerne un système permettant d'obtenir une consommation en oxygène et similaire par irradiation de lumière sur une rétine. Un système de mesure de consommation d'oxygène comporte une source de lumière laser (3), un premier moyen de détection optique (3) ; une source de lumière à multiples longueurs d'onde (4) ; un second moyen de détection optique (5) ; et un contrôleur (6) connecté au premier moyen de détection optique (3) et au second moyen de détection optique (5), qui permet d'obtenir un flux sanguin dans une rétine à l'aide d'un signal détecté par le premier moyen de détection optique (3), d'obtenir une saturation en oxygène à l'aide d'un signal détecté par le second moyen de détection optique (5), et d'obtenir une variation de la consommation d'oxygène dans la rétine à l'aide du flux sanguin dans la rétine et de la saturation en oxygène.
PCT/JP2007/000308 2007-03-22 2007-03-27 Système de mesure de consommation d'oxygène et dispositif de diagnostic WO2008117338A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-074590 2007-03-22
JP2007074590 2007-03-22

Publications (1)

Publication Number Publication Date
WO2008117338A1 true WO2008117338A1 (fr) 2008-10-02

Family

ID=39788083

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/000308 WO2008117338A1 (fr) 2007-03-22 2007-03-27 Système de mesure de consommation d'oxygène et dispositif de diagnostic

Country Status (1)

Country Link
WO (1) WO2008117338A1 (fr)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8187201B2 (en) 1997-01-27 2012-05-29 Lynn Lawrence A System and method for applying continuous positive airway pressure
WO2012130249A1 (fr) 2011-03-31 2012-10-04 Aarhus Universitet Système pour évaluer l'extraction de substance tissulaire
CN103251413A (zh) * 2012-02-21 2013-08-21 北京超思电子技术股份有限公司 一种耳机和血氧检测系统
US8666467B2 (en) 2001-05-17 2014-03-04 Lawrence A. Lynn System and method for SPO2 instability detection and quantification
US8728001B2 (en) 2006-02-10 2014-05-20 Lawrence A. Lynn Nasal capnographic pressure monitoring system
US9042952B2 (en) 1997-01-27 2015-05-26 Lawrence A. Lynn System and method for automatic detection of a plurality of SPO2 time series pattern types
US9053222B2 (en) 2002-05-17 2015-06-09 Lawrence A. Lynn Patient safety processor
US9468378B2 (en) 1997-01-27 2016-10-18 Lawrence A. Lynn Airway instability detection system and method
US10354753B2 (en) 2001-05-17 2019-07-16 Lawrence A. Lynn Medical failure pattern search engine
CN110432861A (zh) * 2019-08-12 2019-11-12 北京大学 一种动态光刺激视网膜血氧饱和度测量系统及其测量方法
US11864909B2 (en) 2018-07-16 2024-01-09 Bbi Medical Innovations, Llc Perfusion and oxygenation measurement

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002238850A (ja) * 2001-02-19 2002-08-27 Canon Inc 検眼装置
JP2002291711A (ja) * 2001-03-29 2002-10-08 Sadako Honda 血流量計測装置及び血圧計
JP2006158547A (ja) * 2004-12-03 2006-06-22 Topcon Corp 分光眼底画像データ測定装置及び測定方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002238850A (ja) * 2001-02-19 2002-08-27 Canon Inc 検眼装置
JP2002291711A (ja) * 2001-03-29 2002-10-08 Sadako Honda 血流量計測装置及び血圧計
JP2006158547A (ja) * 2004-12-03 2006-06-22 Topcon Corp 分光眼底画像データ測定装置及び測定方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BEACH J. ET AL.: "Spectral Reflectance Technique for Retinal Blood Oxygen Evaluation in Humans", PROCEEDINGS OF THE 31ST APPLIED IMAGERY PATTERN RECOGNITION WORKSHOP 2002 IEEE, 16 February 2002 (2002-02-16), pages 117 - 123, XP003024529 *

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9042952B2 (en) 1997-01-27 2015-05-26 Lawrence A. Lynn System and method for automatic detection of a plurality of SPO2 time series pattern types
US8187201B2 (en) 1997-01-27 2012-05-29 Lynn Lawrence A System and method for applying continuous positive airway pressure
US9468378B2 (en) 1997-01-27 2016-10-18 Lawrence A. Lynn Airway instability detection system and method
US8932227B2 (en) 2000-07-28 2015-01-13 Lawrence A. Lynn System and method for CO2 and oximetry integration
US10058269B2 (en) 2000-07-28 2018-08-28 Lawrence A. Lynn Monitoring system for identifying an end-exhalation carbon dioxide value of enhanced clinical utility
US10297348B2 (en) 2001-05-17 2019-05-21 Lawrence A. Lynn Patient safety processor
US11439321B2 (en) 2001-05-17 2022-09-13 Lawrence A. Lynn Monitoring system for identifying an end-exhalation carbon dioxide value of enhanced clinical utility
US10366790B2 (en) 2001-05-17 2019-07-30 Lawrence A. Lynn Patient safety processor
US8666467B2 (en) 2001-05-17 2014-03-04 Lawrence A. Lynn System and method for SPO2 instability detection and quantification
US10354753B2 (en) 2001-05-17 2019-07-16 Lawrence A. Lynn Medical failure pattern search engine
US8862196B2 (en) 2001-05-17 2014-10-14 Lawrence A. Lynn System and method for automatic detection of a plurality of SP02 time series pattern types
US10032526B2 (en) 2001-05-17 2018-07-24 Lawrence A. Lynn Patient safety processor
US9053222B2 (en) 2002-05-17 2015-06-09 Lawrence A. Lynn Patient safety processor
US8728001B2 (en) 2006-02-10 2014-05-20 Lawrence A. Lynn Nasal capnographic pressure monitoring system
WO2012130249A1 (fr) 2011-03-31 2012-10-04 Aarhus Universitet Système pour évaluer l'extraction de substance tissulaire
CN103251413A (zh) * 2012-02-21 2013-08-21 北京超思电子技术股份有限公司 一种耳机和血氧检测系统
US11864909B2 (en) 2018-07-16 2024-01-09 Bbi Medical Innovations, Llc Perfusion and oxygenation measurement
CN110432861A (zh) * 2019-08-12 2019-11-12 北京大学 一种动态光刺激视网膜血氧饱和度测量系统及其测量方法

Similar Documents

Publication Publication Date Title
WO2008117338A1 (fr) Système de mesure de consommation d'oxygène et dispositif de diagnostic
US10098592B2 (en) Blood flow image diagnosing device and method
CN108471950B (zh) 用于进行经腹胎儿血氧饱和度监测的系统、装置及方法
US7502639B2 (en) Analysis of retinal metabolism over at least a portion of a cardiac cycle
US6305804B1 (en) Non-invasive measurement of blood component using retinal imaging
JP3701031B2 (ja) 非侵襲血液検査装置
JP6086345B2 (ja) 眼科装置
JP6550745B2 (ja) 血流計測装置
US10357165B2 (en) Method and apparatus for acquiring bioinformation and apparatus for testing bioinformation
AU6347600A (en) Adaptive calibration pulsed oximetry method and device
US20210298652A1 (en) Hemoglobin measurement from a single vessel
Smith et al. Oxygen saturation measurements of blood in retinal vessels during blood loss
US20210272283A1 (en) Ophthalmologic information processing apparatus, ophthalmologic imaging apparatus, ophthalmologic information processing method, and recording medium
WO2017117668A1 (fr) Cartographie de l'oxygénation sanguine du nerf optique en ligne et en temps réel
US20230064792A1 (en) Illumination of an eye fundus using non-scanning coherent light
JPH11323A (ja) 非侵襲血液分析装置
Patil et al. Methods and devices to determine hemoglobin non invasively: A review
Smith et al. Minimizing the influence of fundus pigmentation on retinal vessel oximetry measurements
Smith et al. Retinal vessel oximetry: toward absolute calibration
JP6776313B2 (ja) 血流計測装置
US20240130612A1 (en) Ophthalmologic information processing apparatus, ophthalmologic apparatus, ophthalmologic information processing method, and recording medium
Rasta et al. Spectroscopic imaging of the retinal vessels using a new dual-wavelength
Yokoi et al. Estimation of individual response in finger blood concentration change under occlusion on human arm using speckle patterns
JP2023032223A (ja) 生体情報解析装置
WO2023018846A1 (fr) Détermination optique d'un paramètre de variabilité cardiovasculaire indépendant de contributions cutanées

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07736965

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: JP

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC, EPO FORM 1205A DATED 28/12/2009

122 Ep: pct application non-entry in european phase

Ref document number: 07736965

Country of ref document: EP

Kind code of ref document: A1